Pregnancy induced hypertension (PIH) causes hypertensive cerebropathy, deep vein thrombosis, pulmonary embolismlung edema, intrauterine growth retardation, and premature delivery. It is therefore considered to be a serious disease that affects both mother and fetus. However, the mechanism through which PIH induces its clinical symptoms is unknown. At first, damage to vascular endothelial cells induces vasoconstriction and hemoconcentration, resulting in fetoplacental circulation dysfunction. Then, clinical symptoms such as hypertension and protein urea are induced.
2)
These differences may depend on (1) the activity of prostaglandin production enzymes, (2) the content of these enzymes, and (3) the activity of inhibitors for these enzymes. Satoh et al. reported that the activity of enzymes such as cyclooxygenase-2 (COX-2), which takes part in the synthesis of PGI 2 , is decreased in the endothelium of the umbilical vein in patients with severe PIH, resulting in an imbalance in the PGI 2 -TXA 2 system that leads to TXA 2 predominance. 3) However, in their report, no distinction between COX-1 and COX-2 was made because the isozymes of COX had not yet been discovered. In addition, Keirse et al. determined the contents of COX and PGI 2 synthetase using an immunoradiometric assay with monoclonal antibody. 4, 5) In their report, COX was induced and increased with increasing gestational age, but there was no difference in the level of COX between patients suffering from PIH and normal pregnant women. However, they did not distinguish between COX-1 and COX-2. It is now known that COX isozymes exist and that the inducible type enzyme, COX-2, is a key enzyme in various illnesses. Therefore, it is necessary to reexamine the activity and content of these enzymes.
In the present study, we determined the expression of phospholipase A 2 (PLA 2 ), COX-2, and PGI 2 synthase, which play important roles in PGI 2 production by real time reverse transcription-polymerase chain reaction (RT-PCR). We compared the expression of these enzymes between PIH sufferers and normal pregnant women. Women who maintained a diastolic/systolic blood pressure of Ͼ160/110 mmHg with or without protein urea were defined as having severe PIH according to the definition of the Japan Society of Obstetrics and Gynecology. The research protocol was approved by the ethics committee of Saitama Medical Center, which established the procedures for obtaining informed consent. All pregnant women in this study were informed of the purpose and design of this study and gave their consent. The mean gestational age at delivery in the normal and severe PIH pregnant groups was 37.2Ϯ0.4 weeks (37-38 weeks) and 31.2Ϯ4.3 weeks (24-37 weeks), respectively. The mean gestational age was significantly lower in the PIH pregnant group than in normal pregnant group (pϽ0.01).
MATERIALS AND METHODS

Materials
Immunohistology Immunohistochemical staining of placental tissues was performed using the streptavidin labeled biotinylation method. Placental sections were fixed in paraffin. After deparaffinization, the antigen was activated by boiling the sections in citrate buffer solution (pH 6.0) mixed with autoclave (121°C for 1 min), and endogenous peroxidase was then eliminated with 3% hydrogen peroxide in methanol. The sections were then placed on slides and treated with 10% goat normal serum, before being incubated with primary polyclonal antibody against COX-2 antigen (dilution 1 : 100) for 60 min at room temperature. Staining was completed using a SAB-PO(R) kit. Normal rabbit serum was used as the negative control.
Real Time Reverse Transcription-PCR (RT-PCR)
Placental tissue samples were obtained from the middle of the placentas, which were removed immediately after expulsion. The amnion and decidua were removed from the tissue samples. The tissue samples were then immediately washed with phosphate buffered saline to remove the excess blood and stored at Ϫ80°C until further processing. The tissue (0.5 g) was homogenized in 5 ml ice cold ISOGEN ® using a Polytron homogenizer for 2 min. The resulting homogenate was centrifuged at 5000ϫg for 15 min at 4°C, and total RNA was then extracted from 1 ml supernatant. cDNA was synthesized from the total RNA using reverse transcriptase. Specific primer pairs for PLA 2 , COX-2, PGI 2 synthase, and GAPDH (internal standard) were synthesized ( Table 1) . The reaction mixture contained the above primer, SYBR ® premix Ex Taq TM , ROX Reference Dye, DNA extract, and distilled water. After denaturation for 10 s at 95°C, a cycle of reaction of 5 s at 95°C and 30 s at 60°C was repeated until the product yield reached the threshold. The amplification products were treated with 6% agarose gel electrophoresis and ethidium bromide staining. The intensity of the ethidium bromide staining was detected at 320 nm.
Statistical Analysis Statistical analysis was performed by the Student t-test. The results of the RT-PCR are shown as the meanϮstandard deviation (S.D.) and p values Ͻ0.05 were accepted as statistically significant.
RESULTS
Immunohistology COX-2 immunoreactivity was found in the amnia and decidua. There was also immunoreactivity in the chorionic villi, which allow material exchange among mother and fetus, as well as in the placental vascular smooth muscle (Fig. 1) . Similar results were reported for PLA 2 and PGI 2 synthase immunoreactivity. 6, 7) No positive staining could be found for negative control (data not shown). As a result, we confirmed the existence of COX-2 in placental villous tissue before the real time PCR experiment. Significant differences were not seen between normal and preeclampsia placental tissues (data not shown).
RT-PCR In order to identify the specificity of each primer, agarose gel electrophoresis was performed. Bands of PLA 2 , COX-2, and PGI 2 synthetase were detected at 66 bp, 80 bp, and 67 bp, respectively (data not shown). The COX-2 expression in the PIH pregnant group was significantly decreased to approximately 51% of the value in the control group. Furthermore, the PGI 2 synthase expression in the PIH pregnant group was significantly decreased to about 68% of the control value. However, no significant differences in PLA 2 expression were detected between the PIH and normal pregnant groups (Table 2 ). Figure 2 shows the distribution of (A) PLA 2 /GAPDH ratios in the normal (0.014-0.008) and PIH (0.017-0.004) groups, (B) COX-2/GAPDH ratios in the normal (0.095-0.051) and PIH (0.053-0.009) groups, and (C) PGI 2 synthetase/GAPDH ratios in the normal (0.043-0.023) and PIH (0.038-0.005) groups. Significant differences were not seen between preeclampsia and superimposed preeclampsia.
DISCUSSION
In many reports, difference of normal and PIH pregnant women in COX-1 and COX-2 content in placental tissues was discussed. Wetzka et al. reported that there were no significant differences in COX-1 and COX-2 expression between precritical and postcritical PIH sufferers. 8) On the other hand, Borekci et al. reported that the COX-1 and COX-2 activity in severe and mild PIH patients was significantly lower than that in a normal pregnant group. 9) No differences in PGI 2 synthase or TXA 2 synthase were reported between normal and PIH pregnant groups. 10) In villi and deciduas, no Gene   PLA 2  Forward 5Ј-GAC TGG AGA GCC ACC CTG AAG  Reverse 5Ј-CGG CGT TCA GGT ACG TGT C  COX-2  Forward 5Ј-GCG AGG GCC AGC TTT CA  Reverse 5Ј-CAG AGT TTC ACC GTA AAT ATG ATT TAA  PGI 2 Forward 5Ј-CCA CGC ACC CAT GAA AGC synthase Reverse 5Ј-TGG CGA AAG GTG TGG AAG A differences in COX-1 and COX-2 expression were found between normal and PIH pregnant groups, but the TXA 2 synthase content was increased in the PIH pregnant group. 11) In the present study, the existence of COX-2 in normal and PIH placental tissues became clear as a result of immunohistochemical staining. However, there was no difference for COX-2 staining. Therefore, the mRNA levels of tissue samples were evaluated by RT-PCR which is sensitive method.
Result for RT-PCR, COX-2 and PGI 2 synthase expressions ware significantly decreased in severe PIH. Furthermore, the rate of decrease of COX-2 was more marked than that of PGI 2 synthase (Table 2) . Generally, COX is regarded as a rate-limiting enzyme in prostaglandin production. Therefore, our data that indicate the importance of COX-2 in PIH may be valid. The decrease in COX-2 and PGI 2 synthase expression in severe PIH indicates a reduction of PGI 2 synthesis, resulting in the PGI 2 -TXA 2 balance leaning towards TXA 2 .
In this study, placental COX-2 expression was significantly decreased in PIH pregnancy compared with normal pregnancy. It is reported that the amount of COX increases with increasing gestational age. 5) In our study, the gestational weeks were significantly smaller in PIH pregnancy than in normal pregnancy. Therefore, we cannot rule out the effect of gestational weeks on COX-2 expression. In order to confirm the effect of the duration, gestational age-matched controls are needed. However, severe PIH leads to early onset, mean- ing that premature labor placentas can be used as matched controls. As COX-2 activity is reported to be lower in premature labor than in full term in placental tissue, 12) using early onset placentas as the normal control may be problematic. Therefore, we cannot rule out possibility that differences in gestational age affect COX-2 content. However, it is difficult to prepare a matched control for severe PIH. We did not investigate the existence of inhibitory factors of COX-2 induction in this study. It has been reported that a serum component found in PIH patients causes damage to villous trophoblasts. 13 ) Therefore, it may be necessary to investigate COX-2 content and inhibitory factors. PIH is not regarded as a disease with a single cause, but rather, it is a syndrome. Thus, various symptoms may be found in PIH. This may be the reason why no established opinion concerning COX-1 and COX-2 in PIH has been reached.
In this study, we revealed that COX-2 expression is significantly reduced in placental tissues from patients with severe PIH. These results suggest that a decrease in COX-2 expression is at least partially responsible for the pushing of the PGI 2 -TXA 2 equilibrium towards TXA 2 .
